Cathepsin V has been proposed as a promising therapeutic target because of its restricted expression under physiological conditions and specific functions during pathological processes in cancerous, cardiovascular, and neurological diseases [3], [4], [23], [24]. The gene discussed is CTSV; the disease is nervous system disorder.